These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24274868)

  • 1. Role of exercise in optimizing the functional status of patients with nonalcoholic fatty liver disease.
    Gerber LH; Weinstein A; Pawloski L
    Clin Liver Dis; 2014 Feb; 18(1):113-27. PubMed ID: 24274868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of NASH: nutritional counseling and physical exercise].
    Yoneda M; Fujita K; Iwasaki T; Maeyama S; Terauchi Y; Nakajima A
    Nihon Rinsho; 2006 Jun; 64(6):1139-45. PubMed ID: 16768122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of diet and nutritional intervention for the management of patients with NAFLD.
    Barrera F; George J
    Clin Liver Dis; 2014 Feb; 18(1):91-112. PubMed ID: 24274867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease: the potential role of nutritional management.
    Leclercq IA; Horsmans Y
    Curr Opin Clin Nutr Metab Care; 2008 Nov; 11(6):766-73. PubMed ID: 18827582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease as a feature of the metabolic syndrome.
    Socha P; Wierzbicka A; Neuhoff-Murawska J; Włodarek D; Podleśny J; Socha J
    Rocz Panstw Zakl Hig; 2007; 58(1):129-37. PubMed ID: 17711101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease.
    Angulo P
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How should we manage patients with non-alcoholic fatty liver disease in 2007?
    Chan HL; de Silva HJ; Leung NW; Lim SG; Farrell GC;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of nonalcoholic fatty liver disease: current status.
    Duvnjak M; Tomasic V; Gomercic M; Smircic Duvnjak L; Barsic N; Lerotic I
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():57-66. PubMed ID: 20388946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease.
    Pacifico L; Arca M; Anania C; Cantisani V; Di Martino M; Chiesa C
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):1010-6. PubMed ID: 23018041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome.
    Moore JB
    Proc Nutr Soc; 2010 May; 69(2):211-20. PubMed ID: 20158939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.
    Kang H; Greenson JK; Omo JT; Chao C; Peterman D; Anderson L; Foess-Wood L; Sherbondy MA; Conjeevaram HS
    Am J Gastroenterol; 2006 Oct; 101(10):2247-53. PubMed ID: 17032189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
    Tilg H; Moschen A
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of weight loss on nonalcoholic fatty liver disease.
    Patel AA; Torres DM; Harrison SA
    J Clin Gastroenterol; 2009; 43(10):970-4. PubMed ID: 19727004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fitness versus fatness: moving beyond weight loss in nonalcoholic fatty liver disease.
    Johnson NA; George J
    Hepatology; 2010 Jul; 52(1):370-81. PubMed ID: 20578153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-alcoholic fatty liver disease in children: a new complication of obesity].
    Bocca G; Stolk RP; Scheenstra R; Sauer PJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(45):2443-7. PubMed ID: 19051794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial.
    Nobili V; Manco M; Devito R; Di Ciommo V; Comparcola D; Sartorelli MR; Piemonte F; Marcellini M; Angulo P
    Hepatology; 2008 Jul; 48(1):119-28. PubMed ID: 18537181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity-independent association of human adenovirus Ad37 seropositivity with nonalcoholic fatty liver disease.
    Trovato GM; Martines GF; Pirri C; Trovato FM; Castro A; Garozzo A; Catalano D
    J Clin Gastroenterol; 2012 Jul; 46(6):e46-54. PubMed ID: 22476041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H; Daram SR
    Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.
    Croci I; Byrne NM; Choquette S; Hills AP; Chachay VS; Clouston AD; O'Moore-Sullivan TM; Macdonald GA; Prins JB; Hickman IJ
    Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise and the liver: implications for therapy in fatty liver disorders.
    Johnson NA; Keating SE; George J
    Semin Liver Dis; 2012 Feb; 32(1):65-79. PubMed ID: 22418889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.